Lateral Flow Assay Market Size to Rise at USD 7.1 Billion by 2026 Due To Rising Government Initiatives And Growing Demand For Point Of Care Testing: Grand View Research Inc.
According to a report, ' Lateral Flow Assay Market Size, Share & Trends Analysis Report By Product (Kits & Reagents, Lateral Flow Readers), By End Use, By Application (Clinical Testing, Veterinary Diagnostics), By Technique, By Region, And Segment Forecasts, 2019 - 2026, lateral flow assays are cellulose based devices used in the detection of a target component in the liquid sample excluding the need for any specialized equipment. Growing prevalence of infectious disease is expected to remain pivotal for market growth in the coming years.
The geriatric population widely suffers from inflammatory and bowel diseases. Although the treatments are available worldwide, there is a huge demand for lateral flow assays since these devices enhance the treatment methods for geriatric population. For instance, according to the U.S. Department of Health & Human Services, the U.S. Government has formed the President's Emergency Plan for AIDS Relief (PEPFAR). This emergency plan works towards the prevention, response and early detection of existing as well new risks related to immune system.
In addition, the rise in prevalence of infectious diseases is expected to propel the market growth in the coming years. According to the WHO, alone in 2019, there were more than 219 million cases of malaria and more than 10 million cases of TB in Africa and South East Asia.
Lateral Flow Assay Market Report Highlights:
Kits & reagents held the largest share based on product as they offer easy, effective, and rapid diagnosis of chronic and infectious diseases
The clinical testing segment held the largest market share in the past years owing to increase in incidence of infectious diseases, rise in pressure to reduce overall healthcare costs, and increasing demand for POC testing devices that can be used at any healthcare setting
Technological advancements in the healthcare sector, innovation in technology and devices, and increase in the adoption of POC testing by patients and healthcare professionals is anticipated to fuel market growth during the forecast period
'Would you Like/Try a Sample Report Click the link below :
Grand View Research has segmented the global lateral flow assay market on the basis of product, application, technique, end use, and region:
Lateral Flow Assay Product Outlook (Revenue, USD Million, 2015 - 2026)
Kits & Reagents
Lateral Flow Readers
Digital/Mobile Readers
Benchtop Readers
Lateral Flow Assay Application Outlook (Revenue, USD Million, 2015 - 2026)
Clinical Testing
Infectious Diseases Testing
Mosquito Borne Disease Testing
Influenza Testing
Sexually Transmitted Infection Testing
HIV Testing
HPV Testing
Chlamydia Testing
Gonorrhea Testing
Syphilis Testing
Others
Hepatitis
Tuberculosis
Others
Cardiac Marker Testing
Troponin-I and T-Testing
CK-MB Testing
BNP and NT-ProBNP Testing
Myoglobin Testing
D-Dimer Testing
Others
Pregnancy & Fertility Testing
Pregnancy Testing
Fertility Testing
Cholesterol Testing/Lipid Profile Testing
Drugs of Abuse Testing
Others
Veterinary Diagnostics
Food safety & Environment Testing
Drug Development & Quality Testing
Lateral Flow Assay Technique Outlook (Revenue, USD Million, 2015 - 2026)
Sandwich Assay
Competitive Assay
Multiplex Detection Assay
Lateral Flow Assay End-use Outlook (Revenue, USD Million, 2015 - 2026)
Hospitals & Clinics
Diagnostic Laboratories
Home Care
Pharmaceutical & Biotechnology Companies
Others
Lateral Flow Assay Regional Outlook (Revenue, USD Million, 2015 - 2026)
North America
U.S.
Canada
Europe
U.K.
Germany
France
Italy
Spain
Russia
Asia Pacific
China
India
Japan
South Korea
Australia
Latin America
Mexico
Brazil
Argentina
MEA
South Africa
Saudi Arabia
UAE
List of Key Players for Lateral Flow Assay Market:
Quidel Corporation
Hologic Inc
Thermo Fisher Scientific Inc
F.Hoffman-La Roche
Siemens AG
Danaher Corporation
Becton Dickinson and Company
Bio-Rad
BioMerieux
PerkinElmer
Have Any Query? Ask Our Experts for More Details on Report :
Browse Related Report @
In-Vitro Colorectal Cancer Screening Tests Market
Explore the BI enabled intuitive market research database, Navigate with Grand View Compass , by Grand View Research, Inc.
About Grand View Research
Grand View Research is a market research and consulting company based in the State of California with headquarters in San Francisco. The company offers consulting services tailored for business organizations to assist them with understanding and exploring their potential on a large scale. At the same time, Grand View Research caters to the individual research needs to provide a customized research service.
Grand View Research is fully committed to offer the best research services in the Industry. Our dedicated team of experienced analysts offer full capability and potential to precisely understand your research needs.
Media Contact
Company Name: Grand View Research, Inc.
Contact Person: Sherry James, Corporate Sales Specialist - U.S.A.
Email: Send Email
Phone: 1888202951
Address: Grand View Research, Inc. 201 Spear Street 1100 San Francisco, CA 94105, United States
City: San Francisco
State: California
Country: United States
Website:

Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.
Most popular stories
Market Research

- Seoul Exchange, One Of Only Two Licensed Platforms For Unlisted Securities, Will Exclusively Use Story To Settle Tokenized Rwas
- Phase 6 Reaches 50% Mark As Mutuum Finance (MUTM) Approaches Next Price Step
- 0G Labs Launches Aristotle Mainnet With Largest Day-One Ecosystem For Decentralized AI
- Solotto Launches As Solana's First-Ever Community-Powered On-Chain Lottery
- Kintsu Launches Shype On Hyperliquid
- Blockchainfx Raises $7.24M In Presale As First Multi-Asset Super App Connecting Crypto, Stocks, And Forex Goes Live In Beta
Comments
No comment